Analysis of Breast Cancer Mortality in the US (JAMA)

Author/Credit: JAMAAbout The Study: Based on four simulation models, breast cancer screening, treatment of stage I to III breast cancer, and treatment of metastatic breast cancer were each associated with reduced breast cancer mortality between 1975 and 2019 in the U.S. EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 16, 2024Media advisory: The full study and editorial are linked to this news release.Embed this link to provide your readers free access to the full-text article This link is live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.25881?guestAccessKey=a28ac933-5836-47a6-94f1-7a04ea2310c9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011624Authors: Sylvia K. Plevritis, Ph.D., of the Stanford University School of Medicine in Stanford, California, is the corresponding author.(doi:10.1001/jama.2023.25881)Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.#  #  #For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.SOURCE: https://media.jamanetwork.com/news-item/analysis-of-breast-cancer-mortality-in-the-us/